A dynamical systems hypothesis of schizophreniaNovember 09, 2007The inconsistent expressions related to schizophrenia are newly structured in a recent study by researchers at the Universitas Pompeau Fabra (Barcelona), and Oxford University. Marco Loh, Edmund Rolls and Gustavo Deco have created a dynamical system framework to discuss the disorder, publishing on November 9, 2007 in the journal PLoS Computational Biology. People with schizophrenia are known to have difficulty in maintaining attention, unstable thoughts, and reduced emotions. Creating a unifying and statistical model to understand these symptoms has always posed a challenge to researchers and clinicians. For this study Loh et al. developed a top-down analytical approach based on the different types of symptoms and related them to instabilities in attractor neural networks in a statistical dynamical framework. The researchers found that a decrease in the excitatory NMDA-mediated synaptically activated receptor conductances reduces the depth of the attractor basins, therefore reducing the stability of attention in the presence of noise caused by the statistically variable firing of neurons, thus increasing distractibility. This reduced depth in the attractor basins destabilizes the activity at the network level. The cognitive symptoms of schizophrenia (like distractibility) could be caused by this attractor instability in the prefrontal cortex
Loh et al. also found that lower firing rates are produced by reducing the excitatory (NMDA) synaptic conductances, which could account in the orbitofrontal cortex for the negative symptoms associated with schizophrenia, such as a reduction of emotions. Decreasing both the NMDA and the inhibitory conductances results in switches between attractor states and jumps from spontaneous activity into one of the attractors. This action may cause symptoms related to temporal lobe dysfunction such as delusions and paranoia. The dynamical framework put forth in this study may better the understanding of the symptoms of schizophrenia, therefore culminating in better treatment for those with the disorder. Public Library of Science | |||||||||||||||||||||
|
Related Schizophrenia News Articles Anti-psychotic drug use in the elderly increases despite drug safety warnings Three regulatory warnings of serious adverse events slowed the growth of use of atypical antipsychotic drugs among elderly patients with dementia, but they did not reduce the overall prescription rate of these drugs. Looking beyond the drug receptor for clues to drug effectiveness Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes in how these drugs are developed and prescribed. Severe, acute maternal stress linked to the development of schizophrenia Pregnant women who endure the psychological stress of being in a war zone are more likely to give birth to a child who develops schizophrenia. Unlocking mystery of why dopamine freezes Parkinson's patients Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery. Human brains pay a price for being big Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution. Estrogen relieves psychotic symptoms in women with schizophrenia When combined with antipsychotic medications, the estrogen estradiol appears to be a useful treatment in women with schizophrenia, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction. Study Shows Promising Results in Deep Brain Stimulation for Treatment-Resistant Depression New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time. Protein marker for schizophrenia risk A protein found in immune cells may be a reliable marker for schizophrenia risk, report researchers in a new proteomics study appearing in the July issue of Molecular and Cellular proteomics. Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals. More Schizophrenia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||